Taipei Exchange - Delayed Quote TWD
Golden Biotechnology Corporation (4132.TWO)
14.95
-0.05
(-0.33%)
At close: April 25 at 2:33:28 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-271,316
-271,316
-245,903
-197,964
-259,597
Investing Cash Flow
-18,637
-18,637
63,470
-114,024
-14,138
Financing Cash Flow
-21,796
-21,796
-26,316
618,272
564,548
End Cash Position
210,888
210,888
523,485
731,567
427,928
Capital Expenditure
-7,970
-7,970
-18,038
-10,153
-10,667
Issuance of Capital Stock
--
--
--
580,000
539,206
Issuance of Debt
--
--
--
72,000
63,000
Repayment of Debt
-6,600
-6,600
-13,613
56,335
-16,978
Free Cash Flow
-279,286
-279,286
-263,941
-208,117
-270,264
12/31/2020 - 6/20/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4172.TWO InnoPharmax Inc.
15.70
+2.61%
4117.TWO General Biologicals Corporation
14.45
+1.40%
6677.TWO Anxo Pharmaceutical Co., Ltd.
18.25
+1.11%
6467.TWO TAHO Pharma
64.40
+11.61%
6621.TWO UniPharma Co., Ltd.
15.35
-3.15%
4166.TWO Orient Pharma Co., Ltd.
30.60
+0.82%
6483.TWO Original BioMedicals Co., Ltd.
12.50
+0.40%
6620.TWO Handa Pharmaceuticals, Inc.
73.70
-2.12%
6932.TWO Mercury Biopharmaceutical Corporation
13.80
+7.39%
6539.TWO DV Biomed Co., Ltd.
72.00
+0.70%